三级医疗中功能性消化不良与胃轻瘫是可互换的综合征,具有共同的临床和病理特征
本研究在多中心注册研究中前瞻性随访944例慢性上消化道症状成人患者48周,其中胃轻瘫组720例(76%),功能性消化不良(FD)组224例(24%)。两组基线临床特征和症状严重程度高度相似,48周临床结局也相似,但42%的初始胃轻瘫患者和37%的FD患者根据胃排空结果被重新分类,且重新分类与症状严重程度变化无关。全层胃活检显示两组均存在Cajal间质细胞和CD206+巨噬细胞丢失。结论认为FD和胃轻瘫在临床和病理上不可区分,应视为同一谱系的器质性胃神经肌肉疾病。
要点
- FD与胃轻瘫患者基线临床特征和症状严重程度高度相似。
- 48周时42%胃轻瘫和37%FD患者根据胃排空结果被重新分类。
- 两组均显示Cajal间质细胞和CD206+巨噬细胞丢失。
核心结论
- FD和胃轻瘫在三级医疗中不能基于临床、病理或胃排空评估区分,应视为同一谱系的器质性胃神经肌肉疾病。
研究设计与样本
- 多中心注册研究,前瞻性随访48周,纳入944例慢性上消化道症状成人患者,胃轻瘫组720例(76%),FD组224例(24%),采用协方差分析和回归模型分析。
主要发现
- 两组基线临床特征和上消化道症状严重程度高度相似,48周临床结局也相似。
- 48周时42%的初始胃轻瘫患者根据胃排空结果被重新分类为FD,37%的FD患者被重新分类为胃轻瘫。
- 重新分类与症状严重程度变化无关联。
- 全层胃活检显示两组与肥胖对照组相比均存在Cajal间质细胞和CD206+巨噬细胞丢失。
关键数值与推荐
- 胃轻瘫定义为胃排空延迟;FD定义为不符合胃排空延迟且符合Rome III标准。
- 48周时42%的胃轻瘫患者重新分类为FD,37%的FD患者重新分类为胃轻瘫。
临床怎么用
- 胃排空结果不稳定,不能可靠反映FD或胃轻瘫的临床症状病理生理,不应单独用于区分两种疾病。
- FD和胃轻瘫应作为同一谱系的器质性胃神经肌肉疾病进行管理。
局限性
- 研究限于三级转诊中心患者,结论外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The aim of this study was to clarify the pathophysiology of functional dyspepsia (FD), a highly prevalent gastrointestinal syndrome, and its relationship with the better-understood syndrome of gastroparesis. METHODS: Adult patients with chronic upper gastrointestinal symptoms were followed up prospectively for 48 weeks in multi-center registry studies. Patients were classified as having gastroparesis if gastric emptying was delayed; if not, they were labeled as having FD if they met Rome III criteria. Study analysis was conducted using analysis of covariance and regression models. RESULTS: Of 944 patients enrolled during a 12-year period, 720 (76%) were in the gastroparesis group and 224 (24%) in the FD group. Baseline clinical characteristics and severity of upper gastrointestinal symptoms were highly similar. The 48-week clinical outcome was also similar but at this time 42% of patients with an initial diagnosis of gastroparesis were reclassified as FD based on gastric-emptying results at this time point; conversely, 37% of patients with FD were reclassified as having gastroparesis. Change in either direction was not associated with any difference in symptom severity changes. Full-thickness biopsies of the stomach showed loss of interstitial cells of Cajal and CD206+ macrophages in both groups compared with obese controls. CONCLUSIONS: A year after initial classification, patients with FD and gastroparesis, as seen in tertiary referral centers at least, are not distinguishable based on clinical and pathologic features or based on assessment of gastric emptying. Gastric-emptying results are labile and do not reliably capture the pathophysiology of clinical symptoms in either condition. FD and gastroparesis are unified by characteristic pathologic features and should be considered as part of the same spectrum of truly "organic" gastric neuromuscular disorders. CLINICALTRIALS. GOV IDENTIFIER: NCT00398801, NCT01696747.
引用
- Pasricha PJ, Grover M, Yates KP, et al. Functional Dyspepsia and Gastroparesis in Tertiary Care are Interchangeable Syndromes With Common Clinical and Pathologic Features. Gastroenterology. 2021. PMID: 33548234. doi:10.1053/j.gastro.2021.01.230
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。